PlainRecalls
FDA Devices Moderate Class II Ongoing

EMBLEM S-ICD, Subcutaneous Implantable Defibrillators, Model A209, sterile.

Reported: November 9, 2022 Initiated: September 30, 2022 #Z-0151-2023

Product Description

EMBLEM S-ICD, Subcutaneous Implantable Defibrillators, Model A209, sterile.

Reason for Recall

There is an incorrect manufacturing date/timestamp within the software which causes an inaccurate display of battery capacity.

Details

Units Affected
7 devices
Distribution
Worldwide distribution - US Nationwide distribution in the countries of AL, AR, CA, CO, DE, GA, IL, IA, MA, MI, MN, NV, NJ, NY, OH, PA, TN, TX, and VA. The countries of Canada, France, Germany, Latvia, Netherlands, Poland, Sweden, Switzerland, and United Kingdom.
Location
Saint Paul, MN

Frequently Asked Questions

What product was recalled?
EMBLEM S-ICD, Subcutaneous Implantable Defibrillators, Model A209, sterile.. Recalled by Boston Scientific Corporation. Units affected: 7 devices.
Why was this product recalled?
There is an incorrect manufacturing date/timestamp within the software which causes an inaccurate display of battery capacity.
Which agency issued this recall?
This recall was issued by the FDA Devices on November 9, 2022. Severity: Moderate. Recall number: Z-0151-2023.